Triochem Products Ltd. — Interim / Quarterly Report 2021

Aug 14, 2021

MANUFACTURERS OF ETHICAL PHARMACEUTICAL, PRODUCTS Registered Office: 4th Floor, Sambava Chambus, Sir. P. M. Road, Fort, Mumbal, Maharashtra, PIN: 400001. Telephone: 00 91 (22) 2266 31580 Fax: 00 91 (22) 2202 4657 Emall: info@anohrav.com Webstte: www. triochemproducts. com Corporate Identity Number: L242 49MH 1972 PLcO 15 544

Ref No: TPL PP 2021629 2021; 14th August 2021

To BSE Linuted Corporate Relationship Dcparfment, PhirozeJeejeebhoyTowers, Dalal Street. Fort. Mumbai: 400 001. Security Code No. 512101. ISIN No.: INE331E01013.

Dear Sir / Madam,

Sub: Outcome Of the Board - Pursuant to Remilation sO and 33 of the SEBI /Listing Obli&ations and Disclosures Reauirementst Rcoulation. 2015

Pursuant to Notice Of Board meeting dated 6th August 2021 the Board meeting was held on today Saturday, 14th August, 2021 at 2.00 p.in. at 4th Floor, Sambava Chambers, Sir P. M Road, Fort, Mumbai: 400001 and has approved the fallowing:

1. The Board approved the Unaudited Financial Results for the quarter ended on 30th June 2021, as reviewed by the Audit Committee, in accordance with Regulation 33 of SEBI Qisting Obligations and Disclosure Requirements) Regulation, 2015.

The Board discussed and chose to reduce activity due to the ongoing Covid-19 pandemic in India as vell as its customers markets, we do not see significant inprovement till overseas mackets opeln completely. Till such time, the Company will complete pending orders and any new order received from regular customers. The Company will temporarily reduce activities till a clearer picture emerges.

The management expects ne impalment to the canying amounts of these assets. The Management will continue too closely monitor any changes to future econondc conditions and asses its impact oin the operation.

The Company has sufficient liquidity to meet its financial obligations. There is ne major impact on the collection from our customers and we are also making regular payments to our suppliers, employees, and other concerned persons. The liquidity position of the company is in comfortable zone.

• 1. The Board noted and took on records the linitcd Review Report for the quarter ended on 50th June 2021 as placed before the Board.
• 1. Take notes on the compliance for the quarter ended 30th June 2021

®

T± L Page 1 of 2

MANUFAc'ruRERs OF ETHlcAL plIARMACEUTlcAI. pRODucTs kegistend office: 4th Floor, Sanbava Chambers, Sir. P. M. Road, IFort, Munibai, Malraffashtra, PIN: 400001. Tdephone: 00 91 (22) 2266 31580 FFax: 00 91 (22) 2202 4657 E-mall: info@amDhrav.com Webslte: www.triochemproducts.com Corporate Identity Number: L242 49MH 1972 PLC015 544

1. Board Meeting commenced at 2.00 p.in. and concluded at 2.40 p.in.

You are requested to take note of the sane. Thankingyou, your faithfuuy, For TRIOCHEM PRODUCTS LIMITED

DIRECTOR DIN: 00312369 Place: Mumbal

®

Kanu Doshi Associates LLP

Chartered Accountants

Mumbai Address : 203. The Sum". Hanuman Road, Westom Express Hishway. vile Pads (E), Mumbal . 400 057 T : 022-2615 0100 / 111 / 112 . F . 022 2615 0113

Puce Address : 123, Sohfab Haw, 21 Sassoon Ftoad, Opp. Jehangir Hosphal, Pure -411001. T : 020 4906 7177 E : info@kdg.co.in . W : ww.kdg.co.in

Independent Auditor.s Review Report on Unaudited Quafterly Flnancial Results of the Company Pursuant to the Regulation 33 of the SEBl (Listing Obl[gations and Disclosure Requirements) Regulat]on8, 2015 (as amended)

TO,

The Board Of Directors of TRlocHEM PRODUCTS LIMITED ("Company")

• 1. We have reviewed the acoompanying statement Of unaudited financial results of TRIOCHEM PRODUCTS LIwllTED ("Company") for the quarter ended June 30. 2021 being submitted by the Company pursuant to Regulation 33 of the SEBl (Listing Obligations and Disclosure Requirements) Regulations, 2015 (as amended), including relevant circulars issued by SEBl from time to time. The statement is the responsibilfty of the Company's management and has been approved by Board of Directors. Our responsibility is to express a conclusion on the Statement based on our review of the Statement, which has been prepared in accordance with the recognition and measurement principles laid down in the Indian Accounting Standard 34 "Interim Financial Reporting" ("lnd As 34"), specified under Section 133 of the Companies Act, 2013, SEBI Circular CIR/CFD/PAC/62/2016 dated 5 July 2016 (hereinafter referred to as 'the SEBI Circular), and other accounting principles generally accepted in India.
• 1. We conducted our review of the statement in accordance with the Standard on Review Engagement (SRE) 2410, `Review Of Interim Financial Information performed by Independent Auditor of the Entfty' issued by the Institute Of Chartered Accountants of India. This standard requires that we plan and perform the review to obtain moderate assurance as to whether the financial statements are free of material misstatement. A review is limited primarily to inquiries of company personnel and an analytical procedure applied to financial data and thus provides less assurance than an audit. We have not performed an audit and accordingly, we do not express an audit opinion.
• 1. Based on our review conducted as above, nothing has come to our attention that causes us to believe that the accompanying statement of unaudited financial results prepared in accordance with applicable Indian Accounting Standards (Ind AS) and other recognized accounting practices and policies has not disclosed the information required to be disclosed in terms of Regulation 33 of the SEBl (Listing Obligations and Disclosure Requirements) Regulations, 2015 including the manner in which it is to be disclosed, or that it contains any material misstatement.

For Kanu Doshi Associates LLP Chartered Accountants Firm Registration No: 104746WAV100096

KUNALSUMANT;LgMhaA'*SJgAnK#AbRYAKUNAL VAKHAB|A %g;;.021 oni 4 14 4co8

Kunal Vakharia Partner Membership No.: 148916 UDIN: 21148916AAAAFZ2977

Place: Mumbai Date: 14th August 2021

MANUFACTURERS OF ETHICAL PHARMACEUTICAL PRODUCTS

Registered Office: 4^th Floor, Sambava Chambers, Sir. P. M. Road, Fort, Mumbai, Maharashtra, PIN: 400001. Telephone: 00.91 (22) 2266 5150 Fax: 00.91 (22) 2202 4657 E-mall: info@amphray.com Website: www.triochemproducts.com Corporate Identity Number: L24249MH1972PLC015544

TRIOCHEM PRODUCTS LIMITED

Registered Office: Sambava Chambers, 4th Floor, Sir P. M. Road, Fort, Mumbai - 400 001

website: www.triochemproducts.com

CIN: L24249MH1972PLC015544

	STATEMENT OF UNAUDITED FINANCIAL RESULTS FOR THE QUARTER ENDED 30TH JUNE 2021
					(Rs. in lakhs) Except EPS
Sr	Particulars		Year Ended
No		30-06-2021	31-03-2021	30-06-2020	31-03-2021
		(Unaudited)	(Audited)	(Unaudited)	(Audited)
$\mathbf{1}$	Income
	(a) Revenue from Operations		773.48		1.393.84
	(b) Other income	18.19	7.54	1.30	13.38
	Total Income from operations	18.19	781.02	1.30	1,407.22
$\overline{2}$	Expenses:
	(a) Cost of materials consumed		0.33	418.48	644.87
	(b) Purchase of stock-in-trade		602.73		602.73
	(c) Changes in inventory of finished goods. work-in-progress and stock-in-trade		125.29	(424.31)	13.41
	(d) Employee benefits expenses	11.50	16.39	16.89	66.91
	(e) Finance costs	0.38	1.37	2.09	10.90
	(f) Depreciation and amortisation expense	2.95	3.54	3.42	13.88
	(g) Other expenses	18.56	37.41	20.04	112.64
	Total Expenses	33.39	787.06	36.61	1,465.33
3	Profit / (Loss) from ordinary activities before exceptional items (1-2)	(15.21)	(6.04)	(35.31)	(58.11)
$\ddot{4}$	Exceptional items
5	Profit / (Loss) before tax $(3 + (-4))$	(15.21)	(6.04)	(35.31)	(58.11)
6	Tax expense
	Current tax	(0.22)	(0.77)	0.02	(0.75)
	Deferred tax	(4.06)	0.32	(8.83)	(12.66)
	Total Tax expenses	(4.28)	(0.45)	(8.81)	(13.41)
7	Profit / (Loss) for the period $(5 + 6)$	(10.93)	(5.59)	(26.50)	(44.70)
18	Other comprehensive income, net of income tax
	A. (i) Items that will be reclassified to profit or Loss	٠	٠
	(ii) Income tax relating to items that will be reclassified to profit or loss
	B. (i) Items that will not be reclassified to profit or Loss	1.68	(1.82)	0.11	(2.34)
	(ii) Income tax relating to items that will not be reclassified to profit or loss	(0.42)	0.46	(0.03)	0.59
	Total Other comprehensive income, net of income tax	1.26	(1.36)	0.09	(1.75)
9	Total Comprehensive income for the period $(8 + \cdot 7)$	(9.67)	(6.95)	(26.42)	(46.45)
10	Paid-up equity share capital (Face value of Rs10/- per share)	24.50	24.50	24.50	24.50
					1.146.69
11	Reserve excluding Revalution Reserves as per balance sheet of previous accounting year
12	Earning per share (EPS) (of Rs.10/- each) (not annualised)
	Ragic / Diluted FPS	(4.46)	(2.28)	(10.82)	(18.25)

$Pro_o$ er Mè hai ۰

4

MANUFACTURERS OF ETHICAL PHARMACEUTICAL PRODUCTS

TRIO CHEM

Registered Office: 4^th Floor, Sambava Chambers, Sir. P. M. Road, Fort, Mumbai, Maharashtra, PIN: 400001. Telephone: 00.91 (22) 2266 3150 Fax: 00.91 (22) 2202 (657 E-mail: info@amphray.com

Website: www.triochemproducts.com Corporate Identity Number: L24249MH1972PLC015544

TRIOCHEM PRODUCTS LIMITED
Notes:
1)	The above unaudited financial results of the Company for the quarter ended June 30, 2021 have been reviewed by the Audit committee of the Board and approved by the Board of Directors at its meeting held on 14.08.2021.
2)	The Unaudited financial results have been prepared in accordance with Indian Accounting Standards (Ind AS), the provisions of the Companies Act, 2013 (the Act), as applicable and guidelines issued by the Securities and Exchange Board of India (SEBI).
3)	The company has adopted Ind AS 116 effective period beginning from April 01, 2019. The effect of adoption of Ind AS 116 on the financial results is insignificant
4)	The Company operates in single segment only, i.e. chemical and pharmaceuticals; therefore, disclosure requirement of Indian Accounting Standard (IND AS-108) "Segment Reporting" is not applicable.
$\vert 5)$	The figure for quarter ended 31st March, 2021 are the balancing figures between audited figures of the full financial year 31st March, 2021 and the reviewed year-to-date figures up to the third quarter of the relevant financial year.
$\vert 6\rangle$	The Company has considered the possible effects that may arise out of the still unfolding COVID-19 pandemic on the carrying amounts of property, plant & equipment, inventories, trade receivables, etc. For this purpose, the Company has considered internal and external sources of information up to the
	date of approval of the Financial Results including credit reports and related information, economic forecasts, market value of certain investments etc. Based on the current estimates, the Company does not expect any significant impact on such carrying values. The impact of COVID-19 on the Company's financial statements may differ from that estimated as at the date of approval of Financial Results.
$\overline{7}$	The Indian Parliament has approved the Code on Social Security, 2020 which would impact the contributions by the company towards Provident Fund and Gratuity. The Ministry of Labour and Employment has released draft rules for the Code on Social Security. 2020 on November 13, 2020. and has invited suggestions from stakeholders which are under active consideration by the Ministry. The Company will assess the impact and its evaluation once the subject rules are notified and will give appropriate impact in its financial statements in the period in which, the Code becomes effective and the related rules to determine the financial impact are published.
8)	The Corresponding figures of the previous quarter / year have been regrouped, recasted and reclassified to make them comparable wherever necessary.
	FOR TRIOCHEM PRODUCTS LIMITED $Pro_{\sigma}$ en rloch, Mullister RAMU S. DEORA DIRECTOR & CEO Place: Mumbai
	DIN: 00312369 Dated: 14th August, 2021

MANUFACTURERS OF ETHICAL PHARMACEUTICAL PRODUCTS

PIN: 400001. Telephone: 00 91 (22) 2266 3150 Fax: 00 91 (22) 2202 4657 E-mall: info@amphrav.com Website: www.triochemproducts.com Corporate Identity Number 124249MH1972PLC015544

TRIOCHEM PRODUCTS LIMITED

Registered Office: Sambava Chambers. 4th Floor, Sir P. M. Road, Fort. Mumbai - 400 001

website: www.triochemproducts.com CIN: L24249MH1972PLC015544

(Rs. in lakhs) Except EPS

EXTRACT OF STATEMENT OF UNAUDITED FINANCIAL RESULTS FOR THE QUARTER ENDED 30TH JUNE 2021
Sr	Particulars	For the	For the	For the	For the Year
No		Quarter	Quarter	Quarter	Ended on
		Ended on	Ended on	Ended on
		$30 - \frac{1}{21}$	31-Mar-21	$30 - Jun - 20$	31-Mar-21
		Audited	Unaudited	Unaudited	Audited
$\vert$ 1	Total Income from operations	18.19	781.02	1.30	1.407.22
$\overline{2}$	Net Profit / (Loss) for the period (before Tax. Exceptional and / or Extraordinary items)	(15.21)	(6.04)	(35.31)	(58.11)
$\overline{\mathbf{3}}$	Net Profit / (Loss) for the period before tax (after Exceptional and / or Extraordinary items)	(15.21)	(6.04)	(35.31)	(58.11)
4	Net Profit / (Loss) for the period after tax (after Exceptional and / or Extraordinary items)	(10.93)	(5.59)	(26.50)	(44.70)
$\overline{\phantom{a}}$	Total Comprehensive Income for the period [Comprising Profit / (Loss) for the period (after	1.26	(1.36)	0.09	(1.75)
	tax) and other Comprehensive Income (after tax)]
6	Equity share capital (Face value Rs.10/- per share)	24.50	24.50	24.50	24.50
$\overline{7}$	Other Equity				1.146.69
18	Earnings per share (of Rs.10/- each) (for continuing and discontinued operations)
	a) Basic (not annualized)	(4.46)	(2.28)	(10.82)	(18.25)
	b) Diluted (not annualized)	(4.46)	(2.28)	(10.82)	(18.25)

Notes:

1) The above unaudited financial results of the Company for the quarter ended June 30, 2021 have been reviewed by the Audit committee of the Board and approved by the Board of Directors at its meeting held on 14.08.2021.

2) The Unaudited financial results have been prepared in accordance with Indian Accounting Standards (Ind AS), the provisions of the Companies Act, 2013 (the Act), as applicable and guidelines issued by the Securities and Exchange Board of India (SEBI).

3) The company has adopted Ind AS 116 effective period beginning from April 01, 2019. The effect of adoption of Ind AS 116 on the financial results is insignificant.

4) The Company operates in single segment only, i.e. chemical and pharmaceuticals; therefore, disclosure requirement of Indian Accounting Standard (IND AS-108) "Segment Reporting" is not applicable.

5) The figure for quarter ended 31st March, 2021 are the balancing figures between audited figures of the full financial year 31st March, 2021 and the reviewed vear-to-date figures up to the third quarter of the relevant financial year.

6) The Company has considered the possible effects that may arise out of the still unfolding COVID-19 pandemic on the carrying amounts of property. plant & equipment, inventories, trade receivables, etc. For this purpose, the Company has considered internal and external sources of information up to the date of approval of the Financial Results including credit reports and related information, economic forecasts, market value of certain investments etc. Based on the current estimates, the Company does not expect any significant impact on such carrying values. The impact of COVID-19 on the Company's financial statements may differ from that estimated as at the date of approval of Financial Results.

7) The Indian Parliament has approved the Code on Social Security, 2020 which would impact the contributions by the company towards Provident Fund and Gratuity. The Ministry of Labour and Employment has released draft rules for the Code on Social Security, 2020 on November 13, 2020, and has invited suggestions from stakeholders which are under active consideration by the Ministry. The Company will assess the impact and its evaluation once the subject rules are notified and will give appropriate impact in its financial statements in the period in which, the Code becomes effective and the related rules to determine the financial impact are published.

8) The Corresponding figures of the previous quarter / year have been regrouped, recasted and reclassified to make them comparable wherever necessary.

9) The above is an extract of the detailed format of financial results filed with the Stock Exchange under Regulation 33 of the SEBI (Listing and Other Disclosure Requirements) Regulation, 2015. The full format of consolidated financial results are available on the Stock Exchange website. www.bseindia.com and on the Company's website www.triochemproducts.com FOR TRIOCHEM PRODUCTS LIMITED

Mutaba

Place: Mumbai Dated: 14th August, 2021

RAMU S. DEORA DIRECTOR & CEO DIN: 00312369